Dinutuximab is a recombinant chimeric monoclonal antibody targeting GD2, with potential anti-cancer activity, used in high-risk neuroblastoma research.
Purity:
>95%
CAS Number:
[1363687-32-4]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted